丹参酮ⅡA对大鼠肝纤维化的干预作用及其调控Ang Ⅱ的分子机制  被引量:24

Intervention and Molecular Mechanism of Ang Ⅱ Regulation of Tanshinone ⅡA on Liver Fibrosis in Rats

在线阅读下载全文

作  者:张翼宙[1] 卢冬冬[1] 董颖[1] 郑如回 ZHANG Yizhou LU Dongdong DONG Ying et al(Zhejiang Chinese Medical University, Hangzhou 310053)

机构地区:[1]浙江中医药大学,杭州310053

出  处:《浙江中医药大学学报》2017年第1期1-10,共10页Journal of Zhejiang Chinese Medical University

基  金:浙江省自然科学基金(LY12H29006)~~

摘  要:[目的]观察丹参酮ⅡA(tanshinone ⅡA,TSN)对四氯化碳(carbontetrachloride,CCl4)致大鼠肝纤维化的干预作用,并以血管紧张素Ⅱ(angiotensin Ⅱ,Ang Ⅱ)受体为靶点探讨相关的作用机制。[方法]SD大鼠随机分为5组,每组6只。除空白对照组外,其余各组大鼠用CCl4诱导肝纤维化模型。治疗组分别给予剂量为21.3mg/(kg·d)、14.2mg/(kg·d)、7.1 mg/(kg·d)的TSN与5%的黄蓍树胶混悬液,模型组和空白对照组给予等容积的5%黄蓍树胶溶液,灌胃1次/d。用药10周后,测定各组大鼠血清中丙氨酸转氨酶(alanine transaminase,ALT)、天冬氨酸转氨酶(aspartate transferase,AST)、Ang Ⅱ的含量,并对各组大鼠肝组织进行HE染色和羟脯氨酸(hydroxyl proline,Hyp)测定,实时荧光定量逆转录PCR(RT-PCR)和免疫组化法(immunohistochemistry,IHC)分别检测I型胶原蛋白(collagen type I,Col I)、缺氧诱导因子-1α(hypoxia inducible Factor-1α,HIF-1α)、血管内皮细胞生长因子(vascular endothelial growth Factor,VEGF)及血管紧张素Ⅱ 1型受体(angiotensin Ⅱ type 1 receptor,AT1R)的m RNA和蛋白表达。[结果]TSN能明显降低肝纤维化大鼠血清中ALT、AST、Ang Ⅱ的水平,降低肝组织中Hyp的含量,抑制胶原纤维的表达,降低Col I、HIF-1α、VEGF及AT1R各m RNA和蛋白表达。[结论]TSN有明显的抗肝纤维化作用,其机制与改善肝脏微循环、减少细胞外基质合成、抑制胶原纤维密切相关。[Objective]To study the protective effect of Tanshinone ⅡA(TSN) on hepatic fibrosis in rats induced by carbontetrachloride(CCl4). [Methods]SD rats were divided into 5 groups with 6 in each group. The hepatic fibrosis rat model was established by CCl4. The rats in TSN groups were ig administrated with TSN(21.3mg/(kg·d), 14.2 mg/(kg·d), 7.1 mg·/(kg·d)) and 5% Tragacanth gum mixed suspension, the rats in control and model group with 5% Tragacanth gum mixed suspension, once daily. After ten weeks, the activities of alanine transaminase(ALT), aspartate transferase(AST), angiotensin Ⅱ(Ang Ⅱ) were tested, and rat liver tissue was tested by Hematoxylin-eosin(HE) staining,hydroxyl proline(Hyp) testing, immunohisto-chemical detection, Real time RT-PCR method.[Results]TSN can obviously inhibit ALT, AST, Ang Ⅱ rise in liver fibrosis rats serum, reduce Hyp in liver tissue and collagen type I(Col I) content, inhibit the increase of collagen fibers, also can reduce the m RNA transcription level of HIF-1 α, VEGF and AT1 R and protein expression. [Conclusion]TSN has obvious anti liver fibrosis effect, and the mechanism is closely related with improving the hepatic microcirculation, decreasing extracellular matrix synthesis,inhibiting the increase of collagen fiber.

关 键 词:TSN 肝纤维化 ANG  AT1R HIF-1Α VEGF 

分 类 号:R331[医药卫生—人体生理学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象